Abstract
Background Transmission of respiratory pathogens, such as Mycobacterium tuberculosis and severe acute respiratory syndrome coronavirus 2, is more likely during close, prolonged contact and when sharing a poorly ventilated space. In clinics in KwaZulu-Natal (KZN) and Western Cape (WC), South Africa, we estimated clinic visit duration, time spent indoors and outdoors, and occupancy density of waiting rooms.
Methods We used unique barcodes to track attendees’ movements in 11 clinics in two provinces, multiple imputation to estimate missing arrival and departure times, and mixed-effects linear regression to examine associations with visit duration.
Results 2,903 attendees were included. Median visit duration was 2 hours 36 minutes (interquartile range [IQR] 01:36–3:43). Longer mean visit times were associated with being female (13.5 minutes longer than males; p<0.001) and attending with a baby (18.8 minutes longer than those without; p<0.01), and shorter mean times with later arrival (14.9 minutes shorter per hour after 0700; p<0.001) and attendance for tuberculosis or ante/postnatal care (24.8 and 32.6 minutes shorter, respectively, than HIV/acute care; p<0.01).
Overall, attendees spent more of their time indoors (median 95.6% [IQR 46–100]) than outdoors (2.5% [IQR 0–35]). Attendees at clinics with outdoor waiting areas spent a greater proportion (median 13.7% [IQR 1– 75]) of their time outdoors.
In two clinics in KZN (no appointment system), occupancy densities of ∼2.0 persons/m2 were observed in smaller waiting rooms during busy periods. In one clinic in WC (appointment system), occupancy density did not exceed 1.0 persons/m2 despite higher overall attendance.
Conclusions Longer waiting times were associated with early arrival, being female, and attending with a young child. Attendees generally waited where they were asked to. Regular estimation of occupancy density (as patient flow proxy) may help staff assess for risk of infection transmission and guide intervention to reduce time spent in risky spaces.
Competing Interest Statement
All authors have completed the ICMJE uniform disclosure form at www.icmje.org and declare: financial support from the Economic and Social Research Council (UK) and from The Bloomsbury SET (Research England) for the submitted work; no financial relationships with any organizations that might have an interest in the submitted work in the previous three years; and no other relationships or activities that could appear to have influenced the submitted work.
Funding Statement
The support of the Economic and Social Research Council (UK) is gratefully acknowledged. The Umoya omuhle study is funded by the Antimicrobial Resistance Cross Council Initiative supported by the seven research councils in partnership with other funders including support from the GCRF (ref. ES/P008011/1). Additional support was received from The Bloomsbury SET (Research England; ref. CCF17-7779). TAY is funded via an NIHR Academic Clinical Fellowship and acknowledges support from the NIHR Imperial Biomedical Research Centre.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study received ethical approval from the Biomedical Research Ethics Committee of the University of KwaZulu-Natal (ref. BE082/18), the Human Research Ethics Committee of the Faculty of Health Sciences of the University of Cape Town (ref. 165/2018), the Research Ethics Committee of Queen Margaret University (ref. REP 0233), and the Observational/Interventions Research Ethics Committee of the London School of Hygiene & Tropical Medicine (ref. 14872).
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data will be made available from the LSHTM repository (Data Compass).
List of abbreviations
- ART
- antiretroviral therapy
- CI
- confidence interval
- HCW
- health care worker
- hh
- hours
- IPC
- infection prevention and control
- IQR
- interquartile range
- KZN
- Kwa-Zulu Natal
- mm
- minutes
- Mtb
- Mycobacterium tuberculosis
- NCD
- noncommunicable disease
- PHC
- primary health care
- REDCap
- Research Electronic Data Capture
- ref.
- reference
- SARS-COV-2
- severe acute respiratory syndrome coronavirus 2
- TB
- tuberculosis
- WC
- Western Cape